Missouri · J7318

Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg in Missouri

Missouri Medicare Avg
$5.10
0% above national avg
National Medicare Avg
$5.08
All states combined
Billed Charge (MO)
$31.18
What providers submit
Est. Commercial (MO)
$13.49
National avg: $14.44
Est. Cash / Self-Pay (MO)
$13.44
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

43.6K
Services in MO
81
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Missouri

Provider Medicare Services
Farmer, Christopher M.D. $5.10 6.2K
Simrell, Elisha PA $5.11 5.8K

Missouri Pricing in Context

In Missouri, CPT code J7318 (Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg) carries an average Medicare payment of $5.10 — 0% above the national benchmark of $5.08. 81 providers across the state submitted claims for this procedure in 2023, performing 43.6K total services. Individual payments in MO ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Missouri is $31.18, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Missouri sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Missouri lands near $13.49, with self-pay cash prices typically around $13.44. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg cost in Missouri?

The average Medicare payment for Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg in Missouri is $5.10, which is 0% above the national average of $5.08. Providers in MO typically bill $31.18 for this procedure.

What does Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg cost with insurance in Missouri?

With commercial insurance in Missouri, Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg costs an estimated $13.49. Without insurance, the estimated cash price is $13.44. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg in Missouri?

81 providers in Missouri billed Medicare for Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg in 2023, performing 43.6K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg cheaper in Missouri than the national average?

No — Hyaluronan Or Derivative, Durolane, For Intra-Articular Injection, 1 Mg costs 0% above the national average in Missouri. The state average Medicare payment is $5.10 compared to $5.08 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial